FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2022180932> ?p ?o ?g. }

• W2022180932 endingPage "287" @default.
• W2022180932 startingPage "277" @default.
• W2022180932 abstract "Chronic kidney disease (CKD) is characterised by the pathological accumulation of extracellular matrix (ECM) proteins leading to progressive kidney scarring via glomerular and tubular basement membrane expansion. Increased ECM synthesis and deposition, coupled with reduced ECM breakdown contribute to the elevated ECM level in CKD. Previous pre-clinical studies have demonstrated that increased plasmin activity has a beneficial effect in the protein overload model of CKD. As plasmin activation is downregulated by the action of the thrombin activated fibrinolytic inhibitor (TAFI), we tested the hypothesis that inhibition of TAFI might increase plasmin activity and reduce ECM accumulation in an in vitro model of glucose induced ECM expansion. Treatment of NRK52E tubular epithelial cells with increasing concentrations of glucose resulted in a 40% increase in TAFI activity, a 38% reduction in plasmin activity and a subsequent increase in ECM accumulation. In this model system, application of the previously reported TAFI inhibitor UK-396082 [(2S)-5-amino-2-[(1-n-propyl-1H-imidazol-4-yl)methyl]pentanoic acid] caused a reduction in TAFI activity, increased plasmin activity and induced a parallel decrease in ECM levels. In contrast, RNAi knockdown of plasmin resulted in an increase in ECM levels. The data presented here indicate that high glucose induces TAFI activity, inhibiting plasmin activation which results in elevated ECM levels in tubular epithelial cells. The results support the hypothesis that UK-396082 is able to reduce TAFI activity, normalising plasmin activity and preventing excess ECM accumulation suggesting that TAFI inhibition may have potential as an anti-scarring strategy in CKD." @default.
• W2022180932 created "2016-06-24" @default.
• W2022180932 creator A5053081343 @default.
• W2022180932 creator A5057652637 @default.
• W2022180932 creator A5059572479 @default.
• W2022180932 date "2013-06-01" @default.
• W2022180932 modified "2023-09-24" @default.
• W2022180932 title "An inhibitor of thrombin activated fibrinolysis inhibitor (TAFI) can reduce extracellular matrix accumulation in an in vitro model of glucose induced ECM expansion" @default.
• W2022180932 cites W1521574535 @default.
• W2022180932 cites W1758955113 @default.
• W2022180932 cites W1868353370 @default.
• W2022180932 cites W1972721037 @default.
• W2022180932 cites W1973138150 @default.
• W2022180932 cites W1974144714 @default.
• W2022180932 cites W1974709342 @default.
• W2022180932 cites W1977017159 @default.
• W2022180932 cites W1977497608 @default.
• W2022180932 cites W1993645457 @default.
• W2022180932 cites W2006926974 @default.
• W2022180932 cites W2011501529 @default.
• W2022180932 cites W2012194625 @default.
• W2022180932 cites W2012719951 @default.
• W2022180932 cites W2024694557 @default.
• W2022180932 cites W2029453461 @default.
• W2022180932 cites W2038320709 @default.
• W2022180932 cites W2042716979 @default.
• W2022180932 cites W2059107132 @default.
• W2022180932 cites W2061853640 @default.
• W2022180932 cites W2066822578 @default.
• W2022180932 cites W2073574105 @default.
• W2022180932 cites W2080932123 @default.
• W2022180932 cites W2107908226 @default.
• W2022180932 cites W2108244474 @default.
• W2022180932 cites W2108872143 @default.
• W2022180932 cites W2112528128 @default.
• W2022180932 cites W2120136262 @default.
• W2022180932 cites W2122835644 @default.
• W2022180932 cites W2127336805 @default.
• W2022180932 cites W2142154499 @default.
• W2022180932 cites W2147339154 @default.
• W2022180932 cites W2148081733 @default.
• W2022180932 cites W2165178639 @default.
• W2022180932 cites W2169713833 @default.
• W2022180932 cites W4256109828 @default.
• W2022180932 cites W2078015083 @default.
• W2022180932 doi "https://doi.org/10.1016/j.matbio.2013.01.006" @default.
• W2022180932 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23369837" @default.
• W2022180932 hasPublicationYear "2013" @default.
• W2022180932 type Work @default.
• W2022180932 sameAs 2022180932 @default.
• W2022180932 citedByCount "10" @default.
• W2022180932 countsByYear W20221809322014 @default.
• W2022180932 countsByYear W20221809322015 @default.
• W2022180932 countsByYear W20221809322016 @default.
• W2022180932 countsByYear W20221809322017 @default.
• W2022180932 countsByYear W20221809322018 @default.
• W2022180932 countsByYear W20221809322020 @default.
• W2022180932 countsByYear W20221809322021 @default.
• W2022180932 crossrefType "journal-article" @default.
• W2022180932 hasAuthorship W2022180932A5053081343 @default.
• W2022180932 hasAuthorship W2022180932A5057652637 @default.
• W2022180932 hasAuthorship W2022180932A5059572479 @default.
• W2022180932 hasConcept C126322002 @default.
• W2022180932 hasConcept C134018914 @default.
• W2022180932 hasConcept C181199279 @default.
• W2022180932 hasConcept C185592680 @default.
• W2022180932 hasConcept C189165786 @default.
• W2022180932 hasConcept C2776825266 @default.
• W2022180932 hasConcept C2781071845 @default.
• W2022180932 hasConcept C55493867 @default.
• W2022180932 hasConcept C71924100 @default.
• W2022180932 hasConcept C86803240 @default.
• W2022180932 hasConcept C95444343 @default.
• W2022180932 hasConceptScore W2022180932C126322002 @default.
• W2022180932 hasConceptScore W2022180932C134018914 @default.
• W2022180932 hasConceptScore W2022180932C181199279 @default.
• W2022180932 hasConceptScore W2022180932C185592680 @default.
• W2022180932 hasConceptScore W2022180932C189165786 @default.
• W2022180932 hasConceptScore W2022180932C2776825266 @default.
• W2022180932 hasConceptScore W2022180932C2781071845 @default.
• W2022180932 hasConceptScore W2022180932C55493867 @default.
• W2022180932 hasConceptScore W2022180932C71924100 @default.
• W2022180932 hasConceptScore W2022180932C86803240 @default.
• W2022180932 hasConceptScore W2022180932C95444343 @default.
• W2022180932 hasFunder F4320307765 @default.
• W2022180932 hasFunder F4320334629 @default.
• W2022180932 hasIssue "5" @default.
• W2022180932 hasLocation W20221809321 @default.
• W2022180932 hasLocation W20221809322 @default.
• W2022180932 hasOpenAccess W2022180932 @default.
• W2022180932 hasPrimaryLocation W20221809321 @default.
• W2022180932 hasRelatedWork W1966504330 @default.
• W2022180932 hasRelatedWork W1979139803 @default.
• W2022180932 hasRelatedWork W1986236063 @default.
• W2022180932 hasRelatedWork W1992410460 @default.
• W2022180932 hasRelatedWork W2030889776 @default.
• W2022180932 hasRelatedWork W2037631372 @default.
• W2022180932 hasRelatedWork W2040058909 @default.

• next